Feltmann Kristin, Hauspie Bert, Dirkx Nicky, Elgán Tobias H, Beck Olof, Van Havere Tina, Gripenberg Johanna
STAD, (Stockholm Prevents Alcohol and Drug Problems), 11364 Region Stockholm, Sweden.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institute & Stockholm Health Care Services, 11364 Region Stockholm, Sweden.
Toxics. 2024 Aug 29;12(9):635. doi: 10.3390/toxics12090635.
Illicit drug use is common among attendees of electronic dance music (EDM) festivals, but is often significantly underreported by participants. The current study aimed to compare the prevalence and over- and under-reporting of illicit drug use among attendees at EDM festivals in two European countries with distinct drug laws and cultures. Self-reported data regarding recent drug use were collected through interviews. Participants' blood alcohol concentrations were measured using a breathalyzer. Recent illicit drug use was assessed through sampling microparticles in the breath and consequent off-site analysis through liquid chromatography and tandem mass spectroscopy. Illicit drug use was higher in Belgium than in Sweden as indicated by self-reports (56.8 vs. 4.3%) and drug testing (37.2 vs. 12.5%). Underreporting was higher in Sweden than in Belgium; in Sweden, only 2.6% reported taking an illicit drug other than cannabis, whereas 11.6% tested positive, while the corresponding figures in Belgium were 36.5% and 36.9%. In both countries, results from self-reporting and drug testing for specific drugs matched poorly at the individual level, indicating unwitting consumption of substances. This study indicates that the drug use prevalence and the likelihood of disclosure may differ between countries or cultures, which should be considered when choosing methods to investigate drug use prevalence.
在电子舞曲(EDM)音乐节的参与者中,非法药物使用情况很常见,但参与者往往大幅少报。本研究旨在比较两个有着不同毒品法律和文化的欧洲国家中,EDM音乐节参与者非法药物使用的流行率以及多报和少报情况。通过访谈收集了关于近期药物使用的自我报告数据。使用呼气酒精含量测定仪测量参与者的血液酒精浓度。通过采集呼气中的微粒并随后通过液相色谱和串联质谱进行现场外分析,来评估近期非法药物使用情况。自我报告(56.8%对4.3%)和药物检测(37.2%对12.5%)结果均表明,比利时的非法药物使用率高于瑞典。瑞典的少报情况高于比利时;在瑞典,只有2.6%的人报告使用了除大麻以外的非法药物,而检测呈阳性的比例为11.6%,而比利时的相应数字分别为36.5%和36.9%。在这两个国家,针对特定药物的自我报告和药物检测结果在个体层面的匹配度都很差,这表明存在不知情的物质消费情况。这项研究表明,不同国家或文化之间的药物使用流行率和披露可能性可能存在差异,在选择调查药物使用流行率的方法时应予以考虑。